The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Assessing the risk of second malignancies after modern radiotherapy
Open accessAbstract
Recent advances in radiotherapy have enabled the use of different types of particles, such as protons and heavy ions, as well as refinements to the treatment of tumours with standard sources (photons). However, the risk of second cancers arising in long-term survivors continues to be a problem. The long-term risks from treatments such as particle therapy have not yet been determined and are unlikely to become apparent for many years. Therefore, there is a need to develop risk assessments based on our current knowledge of radiation-induced carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know
Brenner, D. J., Doll, R., Goodhead, D. T., Hall, E. J., Land, C. E., Little, J. B., Lubin, J. H., Preston, D. L., Preston, R. J., Puskin, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235592100 · Cited by 1,765
Relative biological effectiveness (RBE) values for proton beam therapy
Paganetti, H., Niemierko, A., Ancukiewicz, M., Gerweck, L. E., Goitein, M., Loeffler, J. S., & Suit, H. D. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02754-2 · Cited by 1,364
Radiation-induced second cancers: the impact of 3D-CRT and IMRT
Hall, E. J., & Wuu, C.-S. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00073-7 · Cited by 1,301
TGFβ signalling: a complex web in cancer progression
Ikushima, H., & Miyazono, K. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2853 · Cited by 1,173
Intensity-modulated radiation therapy, protons, and the risk of second cancers
Hall, E. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.027 · Cited by 1,110
Outcomes for children and adolescents with cancer: challenges for the twenty-first century
Smith, M. A., Seibel, N. L., Altekruse, S. F., Ries, L. A. G., Melbert, D. L., O'Leary, M., Smith, F. O., & Reaman, G. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0421 · Cited by 1,026
A review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900
Cited by
Newhauser, W. D., & Zhang, R. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/8/r155 · Cited by 675
Self-citationCarbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
Kamada, T., Tsujii, H., Blakely, E. A., Debus, J., De Neve, W., Durante, M., Jäkel, O., Mayer, R., Orecchia, R., Pötter, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70412-7 · Cited by 562
Self-citationResveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Charged particle therapy—optimization, challenges and future directions
Loeffler, J. S., & Durante, M. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.79 · Cited by 426
Self-citationRadiation induced secondary malignancies: a review article
Dracham, C. B., Shankar, A., & Madan, R. (2018) · Radiation Oncology Journal · doi:10.3857/roj.2018.00290 · Cited by 349
Metadata
- Authors
- Newhauser, W. D., & Durante, M.
- Venue
- Nature Reviews Cancer
- Published
- 2011-05-19
- Volume
- 11
- Issue
- 6
- Pages
- 438-448
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2053000325
- Cited by
- 380
- References
- 91
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing the risk of second malignancies after modern radiotherapy. https://app.cochat.ai/papers/10.1038/nrc3069
- The paper
- Newhauser, W. D., & Durante, M. (2011). Assessing the risk of second malignancies after modern radiotherapy. Nature Reviews Cancer. https://doi.org/10.1038/nrc3069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.